Filings

1 document · 1 match

1. RPRX Royalty Pharma plc 10-K 2026-02-11

   Item 8. Financial Statements and Supplementary Data

   material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing
   1 match in this document Show context Copy citation